These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Serum glucagon after arginine infusion in aged and young subjects. Ferrero E, Casale G, De Nicola P. J Am Geriatr Soc; 1980 Jun; 28(6):285-7. PubMed ID: 6989881 [Abstract] [Full Text] [Related]
3. Serum insulin, pancreatic glucagon and growth hormone levels in response to intravenous infusion of L-arginine in patients with recently detected juvenile diabetes. Lawecki J, Symonides-Lawecka A, Rogala H. Pol Med Sci Hist Bull (1973); 1976 Jun; 15(2):177-82. PubMed ID: 959042 [Abstract] [Full Text] [Related]
4. The effect of somatostatin on the rise of growth hormone and glucagon secretion induced by arginine and L-dopa in diabetic patients. Hansen AP, Christensen SE, Lundbaek K. Scand J Clin Lab Invest; 1975 May; 35(3):205-10. PubMed ID: 1153917 [Abstract] [Full Text] [Related]
5. Glucagon response to hypoglycemia in diabetic neuropathy. Maher TD. Horm Metab Res Suppl; 1980 May; 9():87-9. PubMed ID: 6929783 [Abstract] [Full Text] [Related]
9. Exaggerated glucagon secretion in diabetic and non-diabetic subjects with surgical porto-caval anastomosis. Fallucca F, Ziparo V, Giangrande L, Menzinger G, Stipa S. Horm Metab Res; 1981 Oct; 13(10):545-7. PubMed ID: 7298009 [Abstract] [Full Text] [Related]
10. Comparison of the suppressive effects of elevated plasma glucose and free fatty acid levels on glucagon secretion in normal and insulin-dependent diabetic subjects. Evidence for selective alpha-cell insensitivity to glucose in diabetes mellitus. Gerich JE, Langlois M, Noacco C, Lorenzi M, Karam JH, Korsham PH. J Clin Invest; 1976 Aug; 58(2):320-5. PubMed ID: 783198 [Abstract] [Full Text] [Related]